FermaVir Appoints Finance And Biotech Industry Executive Frederick Larcombe As Chief Financial Officer

03 Mar 2006

·www.biospace.com

NEW YORK--(BUSINESS WIRE)--March 3, 2006--FermaVir Pharmaceuticals, Inc., (OTCBB:FMVR), committed to the development of breakthrough antiviral and other drug therapies, announced the appointment of veteran financial and biotech industry executive Frederick Larcombe as Chief Financial Officer.

Organizations

FermaVir Pharmaceuticals LLC

Indications

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.